BioCentury | Nov 19, 2012
Company News

Boulder Diagnostics sales and marketing update

...CE Mark approval, is offered at the company's clinical diagnostic service laboratory in Mellrichstadt, Germany. Boulder Diagnostics Inc....
BioCentury | Jan 30, 2012
Company News

Boulder Diagnostics, Portland State University deal

...finance research at the university, which will be eligible for royalties. Details were not disclosed. Boulder Diagnostics Inc....
BioCentury | Jan 18, 2010
Company News

Boulder Diagnostics Inc., Multimmune deal

...a Phase I trial to treat colorectal and lung cancers. Financial terms were not disclosed. Boulder Diagnostics Inc....
Items per page:
1 - 3 of 3
BioCentury | Nov 19, 2012
Company News

Boulder Diagnostics sales and marketing update

...CE Mark approval, is offered at the company's clinical diagnostic service laboratory in Mellrichstadt, Germany. Boulder Diagnostics Inc....
BioCentury | Jan 30, 2012
Company News

Boulder Diagnostics, Portland State University deal

...finance research at the university, which will be eligible for royalties. Details were not disclosed. Boulder Diagnostics Inc....
BioCentury | Jan 18, 2010
Company News

Boulder Diagnostics Inc., Multimmune deal

...a Phase I trial to treat colorectal and lung cancers. Financial terms were not disclosed. Boulder Diagnostics Inc....
Items per page:
1 - 3 of 3